On Friday, Century Therapeutics Inc (NASDAQ: IPSC) was 17.89% up from the session before settling in for the closing price of $0.76. A 52-week range for IPSC has been $0.34 – $1.18.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 18.46%. When this article was written, the company’s average yearly earnings per share was at 91.72%. With a float of $45.86 million, this company’s outstanding shares have now reached $86.53 million.
Century Therapeutics Inc (IPSC) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Century Therapeutics Inc stocks. The insider ownership of Century Therapeutics Inc is 47.47%, while institutional ownership is 22.77%. The most recent insider transaction that took place on Dec 12 ’25, was worth 30,352. In this transaction President and CEO of this company bought 52,000 shares at a rate of $0.58, taking the stock ownership to the 3,322,990 shares. Before that another transaction happened on Dec 08 ’25, when Company’s SVP Finance & Operations sold 257 for $0.53, making the entire transaction worth $137. This insider now owns 404,874 shares in total.
Century Therapeutics Inc (IPSC) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.35 earnings per share (EPS) during the time that was better than consensus figure (set at -0.44) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 91.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to 18.46% growth over the previous five years of trading.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
You can see what Century Therapeutics Inc (IPSC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.31, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -0.85 in one year’s time.
Technical Analysis of Century Therapeutics Inc (IPSC)
The latest stats from [Century Therapeutics Inc, IPSC] show that its last 5-days average volume of 2.6 million was superior to 0.83 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 87.84%.
During the past 100 days, Century Therapeutics Inc’s (IPSC) raw stochastic average was set at 90.29%, which indicates a significant increase from 88.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0622 in the past 14 days, which was higher than the 0.0398 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5655, while its 200-day Moving Average is $0.5480. Now, the first resistance to watch is $0.9899. This is followed by the second major resistance level at $1.0798. The third major resistance level sits at $1.2096. If the price goes on to break the first support level at $0.7702, it is likely to go to the next support level at $0.6404. The third support level lies at $0.5505 if the price breaches the second support level.
Century Therapeutics Inc (NASDAQ: IPSC) Key Stats
There are 87,405K outstanding shares of the company, which has a market capitalization of 78.66 million. As of now, sales total 6,590 K while income totals -126,570 K. Its latest quarter income was 0 K while its last quarter net income were -32,540 K.
